Proven Efficacy in Both Laboratory Studies and Real-World Settings
ActivePure® Technology is the technology proven to reduce pathogens in the air and on surfaces in real-time.
ActivePure® Technology vs SARS-CoV-2 (The Virus That Causes COVID-19)
Testing completed in August 2020 (surface) and December 2020 (airborne) has shown remarkable levels of reduction in the virus that causes COVID-19.
Aerus Hydroxyl Blaster with ActivePure® Technology Unit Testing
Testing was done at MRIGlobal, a 3rd party unaffiliated laboratory with no connection to ActivePure® Technology or its affiliates. The reduction percentages were measured incrementally over natural degradation of SARS-CoV-2. Outside of control group - over 99.9% reduction of the SARS-CoV-2 virus.
ActivePure® Technology Is Proven Against a Wide Range of Pathogens
- SARS-CoV-2
- Staphylococcus Aureus
- Aspergillus niger endospores (toxic black mold surrogate)
- H1N1 Influenza (Swine Flu)
- H5N8 Influenza (Bird Flu)
- MRSA
- Bacillus globigii (C. difficile & anthrax surrogate)
- MS2 Bacteriophage - RNA Virus
- Staphylococcus epidermidis (Gram +)
- PhiX-174 - DNA Virus
- Erwinia Herbicola (Gram -)
- Listeria monocytogenes
- Murine Norovirus
- E. coli
- Candida auris (fungus)
- Botrytis cinerea (fungus)
- Sclerotinia sclerotiorum (fungus)
- Legionella pneumophila (bacteria)
- Aspergillus versicolor (fungus)
- Clostridium difficile (endospore)
- Salmonella enterica (bacteria)
ActivePure® Technology has been proven effective against a broad spectrum of clinically relevant pathogens. Every pathogen has a different level of resistance which is outlined in the hierarchy of pathogens below.
Click here to review our COVID-19 specific test results.